# Assessment of CCM in HF With Higher Ejection Fraction

Study · id `cardio:ct-nct05064709` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05064709](<https://clinicaltrials.gov/study/NCT05064709>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05064709

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1500 participants.

## Technical summary

Registry record NCT05064709. Randomized; quadruple masking; primary purpose treatment. Start 2022-02-03 (actual); primary completion 2029-02-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1500 participants (planned count; ClinicalTrials.gov record NCT05064709, source copy `cardio:ctgov-nct05064709-2026-10-23`, retrieved 2026-10-26)
- Started: 2022-02-03 (actual) (ClinicalTrials.gov record NCT05064709, source copy `cardio:ctgov-nct05064709-2026-10-23`, retrieved 2026-10-26)
- Primary completion: 2029-02-01 (anticipated) (ClinicalTrials.gov record NCT05064709, source copy `cardio:ctgov-nct05064709-2026-10-23`, retrieved 2026-10-26)
- Completion: 2029-02-01 (anticipated) (ClinicalTrials.gov record NCT05064709, source copy `cardio:ctgov-nct05064709-2026-10-23`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05064709, source copy `cardio:ctgov-nct05064709-2026-10-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05064709-2026-10-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Assessment of CCM in HF With Higher Ejection Fraction
- Acronym: AIM HIGHer
- Condition: Heart Failure
- Condition: Heart Failure With Preserved Ejection Fraction
- Condition: Heart Failure With Mid Range Ejection Fraction
- Condition: Heart Failure With Moderately Reduced Ejection Fraction
- Condition: Diastolic Heart Failure
- Intervention (Device): Cardiac Contractility Modulation Therapy via OPTIMIZER™ Smart Mini System
- Intervention (Device): OPTIMIZER™ Smart Mini System
- Lead sponsor: Impulse Dynamics
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Heart failure with mildly reduced or preserved ejection fraction (`cardio:hfpef`)
- Registry lists this organization as the lead sponsor: Impulse Dynamics (`cardio:org-impulse-dynamics`)

## Provenance

Content hash: 9b4d5808d02e676af1978021d1dddf62fff5f19566d86168f65b64a5801e7c71
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
